Results 121 to 130 of about 2,640,675 (296)

Integrating the temporal dimension in longitudinal mixed methods research: key methodological considerations for design and implementation

open access: yesHuli yanjiu
Drawing on recent international literature and representative case studies,this paper systematically summarized and interpreted the design logic,key implementation principles,data integration techniques,and common challenges of longitudinal mixed methods
LIU Ning   +5 more
doaj  

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

College students' justification for digital piracy: a mixed methods study

open access: yes, 2012
Click on the DOI link to access the article (may not be free).A mixed methods project was devoted to understanding college students' justification for digital piracy.
Yu, Sz De
core   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

open access: yesMolecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak   +10 more
wiley   +1 more source

Mixed Methods

open access: yes, 2012
This presentation provides and overview of mixed methods as a methodology in the social sciences. Crucially the slides are concerned with issues of research design - not analysis. The presentation ends with some seminar questions to encourage students to
Dr Luke Sloan
core  

Future Challenges for Mixed Methods Research in Nursing and the Health Sciences

open access: yes, 2009
Nursing and health science researchers have, increasingly, embraced mixed methods to guide their exploration of the complex phenomena that infl uence human health. The mixed methods approach offers a fl exibility and depth of insight that is not possible
Andrew, Sharon   +5 more
core   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

Identifying stakeholder preferences for communicating impact from medical research: a mixed methods study [PDF]

open access: yes
Background Documentation of research outcomes using impact case studies (ICS) is increasingly required to demonstrate the wider societal benefits of research.
Viney, I.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy